Gilead Sciences’ drug remdesivir will soon be given to pediatric patients with moderate to severe cases of COVID-19 as part of a clinical trial.
Source: NY Post click here for more…
Children with coronavirus to be enrolled in remdesivir clinical trial
Published in New York City
More from New York CityMore posts in New York City »
Be First to Comment